References
Balla, M., Merugu, G. P., Patel, M., Koduri, N. M., Gayam, V., Adapa, S., Naramala, S., & Konala, V. M. (2020). COVID-19, modern pandemic: A systematic review from front-line health care providers’ perspective. Journal of Clinical Medicine Research, 12(5), 215–229. https://doi.org/10.14740/jocmr4142
Behzadifar, M., Ghanbari, M. K., Bakhtiari, A., Behzadifar, M., & Bragazzi, N. L. (2020). Ensuring adequate health financing to prevent and control the COVID-19 in Iran. International Journal for Equity in Health, 19, 61. https://doi.org/10.1186/s12939-020-01181-9
Carter, B. L. (2016). Evolution of clinical pharmacy in the US and future directions for patient care. Drugs & Aging, 33(3), 169–177. https://doi.org/10.1007/s40266-016-0349-2
Cheong, M. W. L. (2020). "To be or not to be in the ward": The impact of COVID-19 on the role of hospital-based clinical pharmacists—A qualitative study. Journal of the American College of Clinical Pharmacy, 3(8), 1458–1463. https://doi.org/10.1002/jac5.1315
Chin, T. W., Chant, C., & Tanzini, R. (2004). Severe acute respiratory syndrome (SARS): The pharmacist’s role. Pharmacotherapy, 24(8), 705–712. https://doi.org/10.1592/phco.24.8.705.36063
Chui, W. K., & Li, S. C. (2005). Advice-giving on self-medication: Perspectives of community pharmacists and consumers in Singapore. Journal of Clinical Pharmacy and Therapeutics, 30(3), 225–231.
Covington, T. R. (2002). The pharmacist as nonprescription drug therapy manager: Let’s seize the opportunity. Journal of the American Pharmacists Association, 42(3), 518–519.
Ghibu, S., Juncan, A. M., Rus, L. L., Frum, A., Dobrea, C. M., Chis, A. A., Gligor, F. G., & Morgovan, C. (2021). The particularities of pharmaceutical care in improving public health service during the COVID-19 pandemic. International Journal of Environmental Research and Public Health, 18(18), 9776. https://doi.org/10.3390/ijerph18189776
Hoti, K., Jakupi, A., Hetemi, D., Raka, D., Hughes, J., & Desselle, S. (2020). Provision of community pharmacy services during COVID-19 pandemic: A cross-sectional study of community pharmacists' experiences with preventative measures and sources of information. International Journal of Clinical Pharmacy, 42(4), 1197–1206. https://doi.org/10.1007/s11096-020-01078-1
John, C. (2018). The changing role of the pharmacist in the 21st century. Pharmaceutical Journal, 300. https://doi.org/10.1211/PJ.2018.20204131
Kennedy, M. J. (2018). Personalized medicines—Are pharmacists ready for the challenge? Integrated Pharmacy Research and Practice, 7, 113–123. https://doi.org/10.2147/IPRP.S133083
Klepser, M. E., Klepser, D. G., Dering-Anderson, A., Morse, J. A., Smith, J. K., & Klepser, S. A. (2016). Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness. Journal of the American Pharmacists Association, 56(1), 14–21. https://doi.org/10.1016/j.japh.2015.11.008
Martins, A. P., da Costa Miranda, A., Mendes, Z., Soares, M. A., Ferreira, P., & Nogueira, A. (2002). Self-medication in a Portuguese urban population: A prevalence study. Pharmacoepidemiology and Drug Safety, 11(5), 409–414.
Nussbaumer-Streit, B., Mayr, V., Dobrescu, A. I., Chapman, A., Persad, E., Klerings, I., Wagner, G., Siebert, U., Christof, C., Zachariah, C., et al. (2020). Quarantine alone or in combination with other public health measures to control COVID-19: A rapid review. Cochrane Database of Systematic Reviews, 4, CD013574. https://doi.org/10.1002/14651858.CD013574
Paudyal, V., Cadogan, C., Fialová, D., Henman, M. C., Hazen, A., Okuyan, B., Lutters, M., & Stewart, D. (2021). Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries. Research in Social and Administrative Pharmacy, 17(8), 1507–1517. https://doi.org/10.1016/j.sapharm.2020.11.017
Skolaut, M. W. (1980). Moving toward the 21st century. American Journal of Health-System Pharmacy, 37(3), 355–358. https://doi.org/10.1093/ajhp/37.3.355
Song, Z., Hu, Y., Zheng, S., Yang, L., & Zhao, R. (2021). Hospital pharmacists' pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience. Research in Social and Administrative Pharmacy, 17(1), 2027–2031. https://doi.org/10.1016/j.sapharm.2020.03.027
Strand, M. A., Bratberg, J., Eukel, H., Hardy, M., & Williams, C. (2020). Community pharmacists' contributions to disease management during the COVID-19 pandemic. Preventing Chronic Disease, 17, E69. https://doi.org/10.5888/pcd17.200317
Tisman, A. (2010). The rising tide of OTC in Europe: Trends, challenges and new potential in a rapidly evolving market. IMS Health. Retrieved January 23, 2015, from http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Healthcare/Healthcare%20Solutions/Consumers/The_Rising_Tide_Of_OTC_Europe.pdf
Toklu, H. Z., & Hussain, A. (2013). The changing face of pharmacy practice and the need for a new model of pharmacy education. Journal of Young Pharmacists, 5(2), 38–40. https://doi.org/10.1016/j.jyp.2012.09.001
Traulsen, J. M., & Druedahl, L. C. (2018). Shifting perspectives—Planning for the future of the pharmacy profession taking current labor market trends into consideration. Research in Social and Administrative Pharmacy, 14(11), 1189–1194. https://doi.org/10.1016/j.sapharm.2018.02.006
Urick, B. Y., & Meggs, E. V. (2019). Towards a greater professional standing: Evolution of pharmacy practice and education, 1920–2020. Pharmacy, 7(3), 98. https://doi.org/10.3390/pharmacy7030098
Youssef, E., & Wright, D. (2020). Pharmacogenomic testing and its future in community pharmacy. Pharmaceutical Journal, 304, 52–57.
Zheng, S. Q., Yang, L., Zhou, P. X., Li, H. B., Liu, F., & Zhao, R. S. (2021). Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Research in Social and Administrative Pharmacy, 17(1), 1819–1824. https://doi.org/10.1016/j.sapharm.2020.03.012